Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity-Reference-Cited by-同舟云学术

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

Published:2012-06 Issue:6 Volume:187 Page:2131-2139
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ginsberg David¹,Gousse Angelo²,Keppenne Veronique³,Sievert Karl-Dietrich⁴,Thompson Catherine⁵,Lam Wayne⁵,Brin Mitchell F.⁶,Jenkins Brenda⁵,Haag-Molkenteller Cornelia⁵

Affiliation:

1. University of Southern California, Los Angeles

2. Herbert Wertheim College of Medicine, Florida International University, Miami, Florida

3. Université de Liège, Liege, Belgium

4. University of Tuebingen, Tuebingen Germany

5. Allergan, Inc., Irvine, California

6. University of California-Irvine, Irvine, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. The neural control of micturition;Fowler;Nat Rev Neurosci,2008

2. Pharmacotherapy for neurogenic detrusor overactivity;Chancellor;Am J Phys Med Rehabil,2006

3. EAU guidelines on neurogenic lower urinary tract dysfunction;Stohrer;Eur Urol,2009

4. Vesico-ureteric reflux in adult patients with spinal injury;Foley;Br J Urol,1997

5. Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes;Hollingworth;Qual Life Res,2010

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and practical considerations in delivering botulinum neurotoxin to adults with congenital neurogenic lower urinary tract dysfunction with history of genitourinary reconstruction;Continence Reports;2024-09

2. Botulinum toxin therapy in urology: historical aspect;Urology reports (St. - Petersburg);2024-08-08

3. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies;Toxins;2024-08-05

4. Update on Non-Interchangeability of Botulinum Neurotoxin Products;Toxins;2024-06-10

5. OnabotulinumtoxinA is now an important tool for managing pediatric neurogenic lower urinary tract dysfunction;Frontiers in Pediatrics;2024-06-03